L&C Bio has received official approval from the Thai FDA for its 'Re2O' and 'Re2O Fine' products as Class 4 medical devices. This marks a significant entry into Thailand's large medical aesthetics market, which influences regional trends in the ASEAN medical tourism sector.
Source: 더바이오
Read the full story at 더바이오
Illustration: AI-generated.
